Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Government agencies communicate via .gov.sg websites (e.g. go.gov.sg/open). Trusted websites
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

National Drug Formulary

TRANEXAMIC ACID MEVON FILM-COATED TABLETS 500 MG [SIN17452P]

Active ingredients: TRANEXAMIC ACID MEVON FILM-COATED TABLETS 500 MG

View product's general information
Last updated 24 April 2026

Product Info

TRANEXAMIC ACID MEVON FILM-COATED TABLETS 500 MG

[SIN17452P]

Product information

Active Ingredient and Strength

TRANEXAMIC ACID - 500 MG

Dosage Form

TABLET, FILM COATED

Manufacturer and Country

LABIANA PHARMACEUTICALS, S.L.U. - SPAIN

Registration Number

SIN17452P

Licence Holder

NOVEM HEALTHCARE PTE LTD

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

B02AA02

Prescription-only Medicines with Exemptions for Supply without Prescription

NA

Indication

4.1 Therapeutic indications

  • Haemorrhage or risk of haemorrhage in increased fibrinolysis or fibrinogenolysis.

    Local fibrinolysis may occur in the following conditions: Menorrhagia, prostatectomy and bladder surgery, haematuria, gastrointestinal haemorrhage, epistaxis, ulcerative colitis, conisation of the cervix, and dental extraction in patients with coagulopathies.

  • Hereditary angioneurotic oedema.

Dosing

4.2. Posology and method of administration

The recommended standard dose is 2 to 3 tablets of 0.5 g 2 to 3 times daily.

For the indications listed below, the following doses are recommended:

Prostatectomy: Intravenous injection should be given for the first 3 days after surgery; thereafter 1g to 1.5 g orally (2 to 3 tablets) 2 to 3 times daily until macroscopic haematuria is no longer present.

Haematuria: 1 g to 1.5 g orally (2 to 3 tablets) 2 to 3 times daily until macroscopic haematuria is no longer present.

Epistaxis: 1.5 g orally (3 tablets) 3 times a day should be administered for 4 to 10 days.

Menorrhagia: 1 g to 1.5 g orally (2 to 3 tablets) 3 to 4 times daily for 3 to 4 days. Tranexamic acid therapy is initiated when bleeding has become profuse.

Conisation of the cervix: 1.5 g orally (3 tablets) 3 times a day for 12 to 14 days postoperatively.

Dental extraction in patients with coagulopathies: After surgery, 25 mg/kg body weight is given orally 3 to 4 times daily for 6–8 days.

Hereditary angioneurotic oedema: 1 g to 1.5 g orally (2 to 3 tablets) 2 to 3 times daily as intermittent or continuous treatment, depending on whether the patient has prodromal symptoms or not.

For patients with moderate to severe impaired renal function, the following dosages are recommended:

Tranexamic Acid Mevon Dosage Table 1



Method of administration: oral administration.

Contraindications

4.3 Contraindications

Active thromboembolic disease, such as deep vein thrombosis, pulmonary embolism and cerebral thrombosis.

Subarachnoid haemorrhage. The limited clinical experience shows that a reduced risk for re-bleeding is offset by an increase in the rate of cerebral ischaemia.

Hypersensitivity to tranexamic acid or any of the ingredients listed in Section 6.1 List of excipients – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information.